publicações selecionadas
-
artigo académico
- Exosomes modified with anti-MEK1 siRNA lead to an effective silencing of triple negative breast cancer cells. Biomaterials Advances. 2023
- New advances in exosome-based targeted drug delivery systems. Critical Reviews in Oncology Hematology. 2022
- Dual release of a hydrophilic and a hydrophobic osteogenic factor from a single liposome. Nanoscale. 2016
- Antibacterial activity of chitosan nanofiber meshes with liposomes immobilized releasing gentamicin. Acta Biomaterialia. 2015
- On the use of dexamethasone-loaded liposomes to induce the osteogenic differentiation of human mesenchymal stem cells. International Review of Neurobiology. 2015
- Immobilization of bioactive factor-loaded liposomes on the surface of electrospun nanofibers targeting tissue engineering. Biomaterials Science. 2014
- Instructive nanofibrous scaffold comprising runt-related transcription factor 2 gene delivery for bone tissue engineering. ACS Nano. 2014
-
artigo de conferência
-
documento
- Exosome-mediated MEK1 silencing is a promising approach against triple negative breast cancer regression 2022
- Surface engineering of exosomes led to an enhanced uptake by triple negative breast cancer cells 2021
- Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy 2021
- Engineered exosome-mediated delivery of RNAi therapeutics towards triple negative breast cancer therapy 2021
- Peptide-mediated targeted delivery system towards triple negative breast cancer treatment 2020
- Advanced Antibacterial Wound Dressing Produced with Natural-origin Materials 2014
- Immobilization of bioactive factor-loaded liposomes at the surface of electrospun nanofibers targeting tissue engineering strategies 2013
- Induction of human mesenchymal stem cells osteogenesis by bioactive agent-releasing liposomes. International Review of Neurobiology. 2012
- BioTeams : do laboratório para o mercado. Boletim de Biotecnologia. 2011